2871 related articles for article (PubMed ID: 28017355)
1. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
2. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ
Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658
[TBL] [Abstract][Full Text] [Related]
3. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters.
Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964
[TBL] [Abstract][Full Text] [Related]
4. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
[TBL] [Abstract][Full Text] [Related]
5. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
6. Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction.
Maffeis C; Morris DA; Belyavskiy E; Kropf M; Radhakrishnan AK; Zach V; Rozados da Conceicao C; Trippel TD; Pieske-Kraigher E; Rossi A; Pieske B; Edelmann F
ESC Heart Fail; 2021 Feb; 8(1):116-128. PubMed ID: 33295106
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry.
Özlek B; Özlek E; Tekinalp M; Kahraman S; Zencirkiran Agus H; Başaran Ö; Kaya BC; Rencüzoğulları İ; Mert KU; Çakır O; Ösken A; Bekar L; Çelik Y; Çil C; Doğan V; Çelik O; Mert GÖ; Memiç Sancar K; Sevinç S; Biteker M
Turk Kardiyol Dern Ars; 2020 Apr; 48(3):234-245. PubMed ID: 32281959
[TBL] [Abstract][Full Text] [Related]
8. Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.
Kaye DM; Silvestry FE; Gustafsson F; Cleland JG; van Veldhuisen DJ; Ponikowski P; Komtebedde J; Nanayakkara S; Burkhoff D; Shah SJ
Eur J Heart Fail; 2017 Dec; 19(12):1690-1697. PubMed ID: 29024227
[TBL] [Abstract][Full Text] [Related]
9. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
10. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
[TBL] [Abstract][Full Text] [Related]
11. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
12. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
Abbasi SA; Shah RV; McNulty SE; Hernandez AF; Semigran MJ; Lewis GD; Jerosch-Herold M; Kim RJ; Redfield MM; Kwong RY
PLoS One; 2016; 11(11):e0164914. PubMed ID: 27812147
[TBL] [Abstract][Full Text] [Related]
13. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
Chieng D; Sugumar H; Segan L; Tan C; Vizi D; Nanayakkara S; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Finch S; Morton JB; Lee G; Mariani J; La Gerche A; Taylor AJ; Howden E; Kistler PM; Kalman JM; Kaye DM; Ling LH
JACC Heart Fail; 2023 Jun; 11(6):646-658. PubMed ID: 36868916
[TBL] [Abstract][Full Text] [Related]
14. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing.
Elshazly MB; Senn T; Wu Y; Lindsay B; Saliba W; Wazni O; Cho L
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089343
[TBL] [Abstract][Full Text] [Related]
15. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
17. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM
JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380
[TBL] [Abstract][Full Text] [Related]
19. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.
Jaubert MP; Armero S; Bonello L; Nicoud A; Sbragia P; Paganelli F; Arques S
Arch Cardiovasc Dis; 2010 Jan; 103(1):3-9. PubMed ID: 20142114
[TBL] [Abstract][Full Text] [Related]
20. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
